New biomarkers useful for preventing, managing acute kidney injury

Reuters Health - 07/10/2020 - New biomarkers can be used in combination with clinical information to improve the prevention and management of acute kidney injury (AKI), according to a consensus report from the Acute Disease Quality Initiative (ADQI). "Significant progress has already been made in the field of AKI biomarkers, which has resulted in a better understanding of the pathophysiology of AKI and improved outcomes with biomarker-guided management," said Dr. Marlies Ostermann of King's College London, Guy's and St. Thomas' Hospital. "The prospect of clearer identification of high-risk patients and different AKI sub-phenotypes and the utilization of appropriately selected biomarkers in routine clinical will support individualized patient-centered care for patients with AKI," she told Reuters Health by email. Dr. Ostermann and colleagues in the ADQI met in 2019 to review available evidence on new AKI biomarkers and develop recommendations regarding AKI ris...

Please login to read the full text of the article.

If you have no account yet, please register now.

Posted on 7 October, 202022 October, 2020